Eli Lilly (LLY) FY2019 results: revenue $22.3 billion, up 3.8% on the year
Eli Lilly & Co. (LLY) reported revenue of $22.3 billion for fiscal 2019, the year ended 31 December 2019, up 3.8% on the year before. Net income was $8.3 billion, up 157.4%, and diluted earnings per share $8.89. The figures are the company's own, from the 10-K it filed with the SEC on 19 February 2020.
Revenue
$22.3 billion
+3.8% on the year
FY2012FY2019
Operating margin
n/a
FY2012FY2019
Net income
$8.3 billion
+157.4% on the year
FY2012FY2019
Diluted EPS
$8.89
+184.0% on the year
FY2012FY2019
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Revenue
22,320
21,493
19,974
+3.8%
Cost of revenue
4,721
4,682
4,448
+0.8%
Gross profit
17,598
16,812
15,526
+4.7%
Gross margin
78.8%
78.2%
77.7%
Research and development
5,595
5,051
5,096
+10.8%
Selling, general and administrative
6,214
5,975
5,982
+4.0%
Interest expense
401
242
225
+65.2%
Pre-tax income
5,266
3,680
2,305
+43.1%
Income tax
628
530
2,391
+18.6%
Effective tax rate
11.9%
14.4%
103.7%
Net income
8,318
3,232
-204
+157.4%
Net margin
37.3%
15.0%
-1.0%
Diluted EPS
$8.89
$3.13
-$0.19
+184.0%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Operating cash flow
4,837
5,524
5,616
-12.5%
Capital expenditure
1,034
1,211
1,077
-14.6%
Free cash flow
3,803
4,314
4,539
-11.9%
Free cash flow margin
17.0%
20.1%
22.7%
Cash from investing
-8,083
1,906
-3,784
Cash from financing
-2,324
-5,905
143
Depreciation and amortisation
1,233
1,609
1,567
-23.4%
Share-based compensation
312
280
281
+11.8%
Buybacks
4,400
4,151
300
+6.0%
Dividends paid
2,410
2,312
2,192
+4.2%
Dividend per share
$2.68
$2.33
$2.12
+15.0%
Diluted shares, weighted
936m
1,034m
1,052m
-9.5%
Balance sheet
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Shareholders' equity
2,607
9,829
11,592
-73.5%
Non-controlling interest
92.2
1,080
75.7
-91.5%
Debt
15,317
10,299
13,647
+48.7%
Operating lease liabilities
487
0.0
n/a
Other liabilities
20,783
22,701
19,666
-8.4%
Total liabilities and equity
39,286
43,908
44,981
-10.5%
Fixed assets
7,873
7,996
7,885
-1.5%
Goodwill
3,679
1,367
1,378
+169.2%
Intangible assets
6,618
1,068
1,354
+519.7%
Investments
2,063
2,094
7,164
-1.4%
Cash and equivalents
2,338
7,321
6,212
-68.1%
Receivables
4,547
4,594
3,977
-1.0%
Inventory
3,191
3,098
3,396
+3.0%
Other assets
8,977
16,371
13,614
-45.2%
Total assets
39,286
43,908
44,981
-10.5%
10-K for the year ended 31 December 2019, filed 19 February 2020: the filing.